All In MedTech

Device Trial Radar · NCT06106373

iotaSOFT Pediatric Study

iotaSOFT Insertion System for Use With Cochlear Implant Surgery in Pediatrics

Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

20

Actual

Start

May 17, 2022

Primary completion

Oct 24, 2024

Study completion Jul 10, 2025

Sponsor

Lead sponsor
iotaMotion, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 30, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 9 months, up to 12 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.

Conditions

  • Hearing Loss, Sensorineural
  • Hearing Loss, Bilateral
  • Hearing Loss, Unilateral

Interventions

  • iotaSOFT Insertion SystemDevice

    robotic assistive technology for cochlear implant electrode insertion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. iotaSOFT Related-serious Adverse Events Measured by Calculating the Proportion of Subjects With One or More SAEs.Time frame: (SAEs) through 30 days after CI surgery/activation

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of Iowa

    Iowa City, Iowa

  • Texas Childrens Hospital

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.